Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Myocardial Reperfusion Injury D015428 20 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Hypercalcemia D006934 13 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Critical Illness D016638 13 associated lipids
Hypocalcemia D006996 12 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Hepatitis D006505 11 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Cuenca J et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. 2004 Transfusion pmid:15383017
Schwenk MH and Blaustein DA Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease. 2004 Clin. Nephrol. pmid:15356968
Tiranathanagul K et al. Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients. 2004 Nephrology (Carlton) pmid:15363053
Silverberg D et al. The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure. 2004 Nephrol. Dial. Transplant. pmid:15031380
Folkert VW Safety of high doses of non-dextran irons. 2003 May-Jun Semin Dial pmid:12753696
Okada DR et al. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. 2003 Mar-Apr J Nucl Cardiol pmid:12673182
Mukhin IV and Nikolenko VIu [Experimental systemic enzyme therapy of gouty and primary glomerulonephritis]. 2003 Jul-Aug Eksp Klin Farmakol pmid:14558349
Souqiyyeh MZ and Shaheen FA Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209438
Zolezzi M Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209437
Flotats A and Carrió I Non-invasive in vivo imaging of myocardial apoptosis and necrosis. 2003 Eur. J. Nucl. Med. Mol. Imaging pmid:12638039
Silverberg DS et al. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. 2003 Isr. Med. Assoc. J. pmid:12811950
Singh J and Gupta KP Calcium glucarate prevents tumor formation in mouse skin. 2003 Biomed. Environ. Sci. pmid:12747003
Yang W et al. The first fluorescent sensor for D-glucarate based on the cooperative action of boronic acid and guanidinium groups. 2003 Chem. Commun. (Camb.) pmid:12703826
Edwards JH Clinical review of the newer intravenous iron therapy options. 2003 Nephrol Nurs J pmid:12674953
Ballinger JR et al. Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. 2003 Nucl Med Commun pmid:12717079
Chuang CL et al. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. 2003 Nephrol. Dial. Transplant. pmid:12543894
Folkert VW et al. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration. 2003 Am. J. Kidney Dis. pmid:12612989
Beshara S et al. Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. 2003 Br. J. Haematol. pmid:12614222
Apostoli P et al. Relationship between PCBs in blood and D-glucaric acid in urine. 2003 Toxicol. Lett. pmid:12919720
Deicher R et al. High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. 2003 Kidney Int. pmid:12846772
Fishbane S Safety issues with iron sucrose. 2003 Am. J. Kidney Dis. pmid:12666081
Séronie-Vivien S et al. Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report. 2003 Med. Oncol. pmid:14514981
Folkert VW Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients. 2003 Nephrol Nurs J pmid:14621635
Breborowicz M et al. Effect of iron sucrose on human peritoneal mesothelial cells. 2003 Eur. J. Clin. Invest. pmid:14636286
Tutor-Crespo MJ et al. Assessment of copper status in epileptic patients treated with anticonvulsant drugs by measuring the specific oxidase activity of ceruloplasmin. 2003 Epilepsy Res. pmid:14642999
Blaustein DA et al. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. 2003 Kidney Int. Suppl. pmid:14531777
Colfer M Achieving optimal patient outcomes with intravenous iron. 2003 Nephrol Nurs J pmid:14533524
Geisser P Reactivity of iron compounds. 2003 Am. J. Kidney Dis. pmid:14582056
Danielson BG and Beshara S Pharmacokinetics and utilization of iron sucrose. 2003 Am. J. Kidney Dis. pmid:14582057
Schröder CH The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. 2003 Pediatr. Nephrol. pmid:12750985
Hanausek M et al. Detoxifying cancer causing agents to prevent cancer. 2003 Integr Cancer Ther pmid:15035900
Tutor-Crespo MJ et al. [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs]. 2002 Oct 16-31 Rev Neurol pmid:12402220
Breymann C Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. 2002 Nov-Dec Blood Cells Mol. Dis. pmid:12547241
Dittrich E et al. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. 2002 Jan-Feb Perit Dial Int pmid:11929146
Shaheen FA et al. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. 2002 Apr-Jun Saudi J Kidney Dis Transpl pmid:17660651
Calcium-D-glucarate. 2002 Altern Med Rev pmid:12197785
Hermida J et al. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment. 2002 Clin. Lab. pmid:12146576
Perewusnyk G et al. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. 2002 Br. J. Nutr. pmid:12117422
Sandstad O et al. D-glucaric acid in common duct bile and relation to choledocholithiasis. 2002 Scand. J. Gastroenterol. pmid:11989842
Ibert M et al. Determination of the side-products formed during the nitroxide-mediated bleach oxidation of glucose to glucaric acid. 2002 Carbohydr. Res. pmid:12039549
Harmankaya O and Eran A Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. 2002 Ren Fail pmid:12071600
Zager RA et al. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. 2002 Am. J. Kidney Dis. pmid:12087566
Michaud L et al. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. 2002 Clin Nutr pmid:12381338
Oldham FB Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable? 2002 Am. J. Kidney Dis. pmid:12407662
Silverberg DS et al. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. 2002 Clin. Nephrol. pmid:12227725
Wali A et al. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. 2002 J Pak Med Assoc pmid:12532571
Hosoya S et al. Identification and characterization of the Bacillus subtilis D-glucarate/galactarate utilization operon ycbCDEFGHJ. 2002 FEMS Microbiol. Lett. pmid:12044674
Boase S and Miners JO In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. 2002 Br J Clin Pharmacol pmid:12445028
Rooyakkers TM et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. 2002 Eur. J. Clin. Invest. pmid:11886426
Kooistra MP et al. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. 2002 Eur. J. Clin. Invest. pmid:11886430